Intellia says its CRISPR-based therapy can be redosed

Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. It’s Wednesday, which means it’a also “The Bear” season 3 premiere day. For my Boston readers, know that Ayo Edebiri has been thinking deeply about the tragedy of the Great Molasses Flood of 1919.

Read the rest…

Read Original Article: Intellia says its CRISPR-based therapy can be redosed »

About The Author